<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
AMENDMENT NO. 1
TO
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report ( Date of earliest event reported):
August 16, 1996
PARACELSUS HEALTHCARE CORPORATION
(Exact name of registrant as specified in its charter)
California 1-12055 95-3565943
(State or other jurisdiction ( Commission (IRS Employer
of incorporation or File Number) Identification No.)
organization)
515 W. Greens Road, Suite 800, Houston, Texas 77067
(Address of principal executive offices)
Registrant's telephone number, including area code:
(281) 774-5100
This report contains 4 pages.
<PAGE> 2
Paracelsus Healthcare Corporation (the "Company") is filing this amendment to
its Current Report on the Form 8-K dated August 16, 1996, to amend Item 7 to
said Current Report.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
Item 7 of the Company's Current Report on Form 8-K dated August 16, 1996 is
amended in its entirety to read as follows:
(a) Financial statements of business acquired.
The following financial statements of Champion are incorporated herein by
reference to the Company's Registration Statement on Form S-4 (Commission File
No. 333-8521):
- Report of independent public accountants, dated
February 27, 1996
- Consolidated balance sheet at December 31, 1994 and
1995
- Consolidated statement of operations for the years
ended December 31, 1993, 1994 and 1995
- Consolidated statement of stockholders' equity for the
years ended December 31, 1993, 1994 and 1995
- Consolidated statement of cash flows for the years
ended December 31, 1993, 1994 and 1995
- Notes to consolidated financial statements
For the financial statements of Champion for the period through March 31,
1996, see the Company's Registration Statements on Form S-1 (Commission File
No. 333-07289 and 333-06713). The financial statements of Champion for the
period through June 30, 1996 as required by Item 7(a) of Form 8-K are deemed
to be "substantially the same" as the financial statements for the period
through March 31, 1996 since operating results have not been omitted for more
than one interim quarter.
(b) Pro forma financial information.
For the pro forma financial statements for the period through March 31, 1996,
see the Company's Registration Statements on Form S-1 (Commission File No.
333-07289 and 333-06713). The pro forma financial statements for the period
through June 30, 1996 as required by Item 7(b) of Form 8-K are deemed to be
"substantially the same" as the pro forma financial statements for the period
through March 31, 1996 since operating results have not been omitted for more
than one interim quarter.
<PAGE> 3
The Company is presently evaluating the need to amend its quarterly reports
on the Form 10-Q for the quarters ended December 31, 1995, March 31, 1996
and June 30, 1996. The Board of Directors has appointed a Special Committee
consisting of non-management members, to supervise and direct the conduct of
an inquiry by outside legal counsel regarding, among other things, the
Company's accounting and financial reporting practices and procedures for
periods before the quarter ending September 30, 1996. Depending upon the
results of the Company's evaluation and the Special Committee's inquiry,
the Company may further amend this Current Report to present the pro forma
financial statements through June 30, 1996, reflecting the revised financial
information for the applicable period.
(c) Exhibits.
2.1(a) Amended and Restated Agreement and Plan of Merger,
dated as of May 29, 1996, by and among Paracelsus,
PC Merger Sub, Inc. and Champion.
99.1 Audited financial statements of Champion for the three
years ended December 31, 1995.
___________________
(a) Incorporated herein by reference to Exhibit 2.1 to the
Company's Registration Statement on Form S-4( Commission
File No. 333-8521).
<PAGE> 4
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Paracelsus Healthcare Corporation
(Registrant)
/s/ JAMES G. VANDEVENDER
Dated: October 30, 1996 By: ____________________________
James G. VanDevender
Executive Vice President,
Chief Financial Officer
& Director
